TP53 and breast cancer: We also showed that a similar dysfunctional phenotype can be observed in mice with 67NR breast cancer cell line-induced tumors (that are known to harbor several mutations such- ER-alpha positive, p53 null, etc. [33]), where we observed reduced EF and FS in tumor-bearing mice.